Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2011 009 865.9 |
96 | EP file number | EAKZ | 11 79 1161.0 |
86 | WO file number | WAKZ | PCT/US2011/061515 |
97 | EP publication number | EPN | 2640362 |
87 | WO publication number | WPN | 2012068535 |
54 | Designation/title | TI | THERAPEUTISCHE ZUSAMMENSETZUNGEN MIT RILPIVIRIN-HCL UND TENOFOVIRDISOPROXILFUMARAT |
51 | IPC main class | ICM (ICMV) | A61K 9/20 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/505 (2006.01), A61K 31/513 (2006.01), A61K 31/675 (2006.01), A61P 31/18 (2006.01) |
22 | DE application date | DAT | Nov 18, 2011 |
96 | EP application date | EAT | Nov 18, 2011 |
86 | WO application date | WAT | Nov 18, 2011 |
43 | Date of first publication | OT | May 24, 2012 |
| Date of publication of grant | PET | Sep 10, 2014 |
71/73 | Applicant/owner | INH | Gilead Sciences, Inc., Foster City, Calif., US; Janssen Sciences Ireland UC, Little Island, County Cork, IE |
72 | Inventor | IN | MENNING, Mark, San FranciscoCalifornia 94122, US; OLIYAI, Reza, BurlingameCalifornia 94010, US; WISER, Lauren, CupertinoCalifornia 95014, US |
74 | Representative | VTR | Marks & Clerk (Luxembourg) LLP, Luxembourg, LU |
| Address for service | | Marks & Clerk (Luxembourg) LLP, 1017 LUXEMBOURG, LU |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 415600 P Nov 19, 2010
|
| Due date | FT FG | Nov 30, 2025 Annual fee for the 15th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002640362 Searchable text:
EP000002640362 Original document:
EP000002640362B1 Searchable text:
EP000002640362B1 Original document:
EP000002640362B2 Searchable text:
EP000002640362B2 Original document:
WO002012068535 Searchable text:
WO002012068535 |
43 | Date of first publication | EVT | May 24, 2012 |
| Date of the first transfer into DPMAregister | EREGT | Nov 8, 2013 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 1, 2024 (Show all update days)(Hide all update days)- Oct 1, 2024
- Due date: changed
- Procedures: Procedure relating to PCT application, Publication of PCT application, 24.05.2012: deleted
- Oct 3, 2023; Sep 29, 2022; Apr 30, 2022; Dec 8, 2021; Nov 11, 2021; Sep 29, 2021; Nov 11, 2020; Dec 5, 2019; Dec 7, 2018; Dec 15, 2017; Dec 7, 2017; Feb 16, 2017; Dec 1, 2016; Oct 27, 2016; Sep 16, 2016; Sep 15, 2016; Dec 9, 2015; Aug 20, 2015; Jul 16, 2015; Dec 14, 2014; Oct 15, 2014; Oct 9, 2014; Sep 12, 2014; Sep 11, 2014
- Historical data not available for this/these date(s)
- Nov 8, 2013
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Sep 15, 2016 |
| Issue number | HN | 43 |
| Year | PJ | 2016 |
| Publication date | VT | Oct 27, 2016 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Gilead Sciences, Inc., Foster City, Calif., US; Janssen Sciences Ireland UC, Little Island, County Cork, IE |
71/73 | Previous applicant/owner | INHF | Gilead Sciences, Inc., Foster City, Calif., US, Janssen R&D Ireland, Little Island, County Cork, IE |